EUVIMEDEUVIMED entdecken
Crossref

Prognostic value of pre-transplant inflammatory and albumin-based composite ratios for pneumonia and mortality after allogeneic hematopoietic stem cell transplantation

Özlem Düvenci Birben, Esma Sevil Akkurt, Derya Yenibertiz, Bilal Çağdaş Seven, Tahir Darçın, Bahar Uncu Ulu, Dicle İskender, Tuğçe Nur Yiğenoğlu, Mehmet Sinan Dal, Fevzi Altuntaş

Anatolian Current Medical Journal · 22.05.2026 · 8 (3) · 504-512

DOI: 10.38053/acmj.1895836 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anatolian Current Medical Journal, online erschienen am 22.05.2026. Verfasst von Özlem Düvenci Birben und 9 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Gefördert von: none.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) are highly susceptible to infectious complications due to immunosuppression and delayed immune reconstitution, with pneumonia remaining a major cause of early morbidity and mortality. Composite inflammation- and protein-based biomarkers, including the C-reactive protein-to-albumin ratio (CAR) and fibrinogen-to-albumin ratio (FAR), have prognostic value in oncology, but their role in predicting pneumonia and survival after allo-HSCT is unclear.

Methods

This retrospective, single-center study included 203 adult allo-HSCT recipients treated between 2020 and 2023. Pre transplant inflammatory and protein-based biomarkers were assessed 7-14 days before transplantation, and Cox proportional hazards regression was used to identify independent predictors of one-year post-transplant pneumonia and mortality.

Results

Pneumonia occurred in 17.7% of patients, and one-year mortality was 41.9%. Although lower albumin, hemoglobin, and platelet levels and higher procalcitonin (PCT) concentrations were associated with pneumonia in univariate analyses, no biomarker independently predicted post-transplant pneumonia after multivariate adjustment. In contrast, pre-transplant PCT (HR=1.020, p

Förderung

  • none

Zitieren

APA

Birben, Ö. D., Akkurt, E. S., Yenibertiz, D., Seven, B. Ç., Darçın, T., Ulu, B. U., İskender, D., Yiğenoğlu, T. N., Dal, M. S., & Altuntaş, F. (2026). Prognostic value of pre-transplant inflammatory and albumin-based composite ratios for pneumonia and mortality after allogeneic hematopoietic stem cell transplantation. Anatolian Current Medical Journal, 8(3), 504-512. https://doi.org/10.38053/acmj.1895836

Vancouver

Birben ÖD, Akkurt ES, Yenibertiz D, Seven BÇ, Darçın T, Ulu BU, et al. Prognostic value of pre-transplant inflammatory and albumin-based composite ratios for pneumonia and mortality after allogeneic hematopoietic stem cell transplantation. Anatolian Current Medical Journal. 2026;8(3):504-512. doi:10.38053/acmj.1895836

BibTeX
@article{Birben2026,
  author = {Birben, Özlem Düvenci and Akkurt, Esma Sevil and Yenibertiz, Derya and Seven, Bilal Çağdaş and Darçın, Tahir and Ulu, Bahar Uncu and İskender, Dicle and Yiğenoğlu, Tuğçe Nur and Dal, Mehmet Sinan and Altuntaş, Fevzi},
  title = {Prognostic value of pre-transplant inflammatory and albumin-based composite ratios for pneumonia and mortality after allogeneic hematopoietic stem cell transplantation},
  journal = {Anatolian Current Medical Journal},
  year = {2026},
  volume = {8},
  number = {3},
  pages = {504--512},
  doi = {10.38053/acmj.1895836}
}
Kostenlos starten →